Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1601-1610 of 2905 for cancer

Edit search filters
  1. Combination Vaccine Immunotherapy (DRibbles) For Patients With Definitively-treated Stage III Non-small Cell Lung Cancer

    Scottsdale/Phoenix, AZ

  2. A Study Of Selpercatinib To Treat Participants With RET-Mutant Medullary Thyroid Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Observation In Patients With Early-Stage Vulvar Cancer Undergoing Sentinel Lymph Node Dissection

    Rochester, MN

  4. Metformin As A Chemoprevention Agent In Non-small Cell Lung Cancer

    Rochester, MN

  5. PET Scan Imaging In Assessing Response In Patients With Esophageal Cancer Receiving Combination Chemotherapy

    Rochester, MN

  6. Dignity Therapy/Life Plan In Patients With Pancreatic Or Advanced Lung Cancer

    Rochester, MN

  7. Study Of Sacituzumab Govitecan (IMMU-132) In Metastatic Or Locally Advanced Unresectable Urothelial Cancer

    Scottsdale/Phoenix, AZ

  8. BPM31510 Administered Intravenously With Or Without Gemcitabine In Advanced Pancreatic Cancer Patients

    Scottsdale/Phoenix, AZ

  9. A First-in-Human Study Of MEN2501 In Participants With Platinum-Resistant Ovarian Cancer

    Rochester, MN

  10. Expanded Access Study Of TAS-102 In Patients With Metastatic Colorectal Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer